Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on DBV TECHNOLOGIES mainly cover share price moves, M&A activity et analyst notes. The stock trades at €1,70 on Euronext Paris, down 6,59% at the last update. This page lists the articles published on DBV TECHNOLOGIES stock to track the share price, company announcements and any item likely to influence market perception.
The Châtillon-based biotech is declining mid-morning, following quarterly results that raise questions about its ability to continue operations. The s…
Third quarter 2026 results published on October 28, 2026 by DBV Technologies illustrate the cost of transitioning to a commercial organization. The au…
The Châtillon biotech recovers mid-morning in an almost stable SBF 120. This movement occurs on the day of its third-quarter results publication, foll…
The Châtillon biotech is losing ground in mid-morning trading, within a SBF 120 index clearly oriented downwards. This decline extends a downward tren…
The Châtillon-based biotech extends its downward streak mid-session, in a Paris market also oriented lower. The security crosses a technical threshold…
The Châtillon biotech is declining again at mid-day, in an SBF 120 that is also retreating. Yesterday's rebound fades away, as the FDA filing has fail…
The Châtillon biotech firm regains some ground at midday, in an SBF 120 oriented upward. This rebound comes after a long series of declines, while the…
The Châtillon biotech company is retreating at midday, within an SBF 120 itself in decline. The stock extends a downward trend established over severa…
The Châtillon biotech company's stock is losing ground in early afternoon trading, while the SBF 120 advances. The filing of the regulatory dossier in…
The rebound welcomed yesterday following the regulatory filing with the FDA is completely erased today. DBV Technologies ranks among the steepest decl…
